Since this induced process is closely related to triglyceride hydrolysis and ketone body production, PPARα-dependent FGF21–JMJD3 autophagy signalling emerges as an important endocrine regulator and a potential therapeutic target in metabolic disorders [135,136,137]. Here, PPARA is linked to metabolic disease.